DPP-4 inhibitor Teneligliptin hydrobromide, Purity ≥98%

Cat. No.: X24-07-ZQ809

DPP-4 inhibitor Teneligliptin hydrobromide, Purity ≥98%

Synonym: 906093-29-6; DPP-4 inhibitor

  • MDL: MFCD23098790
  • CAS Number: 906093-29-6
  • Compound CID: 11996485
Product Size
100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Teneligliptin hydrobromide, soluble in DMSO, water and ethanol, prolongs the action of incretin hormones, thereby improving blood glucose control. It targets Dipeptidyl peptidase-4, DPP-8, DPP-9, and FAP.
Molecular Weight
1257.72
Molecular Formula
C44H65Br5N12O2S2
Targets
Dipeptidyl peptidase-4: 1.75 nM; DPP-8: 189 nM; DPP-9: 150 nM; FAP: >10 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 85 mg/mL (135.16 mM); Water: 85 mg/mL (135.16 mM); Ethanol: 14 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Teneligliptin hydrobromide is employed in research to understand glucose metabolism and diabetic therapy by inhibiting the enzyme DPP-4, which effectively increases insulin secretion.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0